<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03276182</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0851</org_study_id>
    <nct_id>NCT03276182</nct_id>
  </id_info>
  <brief_title>Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery</brief_title>
  <official_title>Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare cataract patients before and after phacoemulsification. Evaluations
      will be performed before and 1 and 3 months following cataract surgery, including parameters
      of dry eye syndrome and MGD. Dry eye syndrome parameters included TBUT, Schirmer's test type
      I, Oxford staining score, and the Ocular Surface Disease Index (OSDI) Questionnaire. MGD
      parameters consisted of lipid layer thickness (LLT), lid margin abnormality, meibum quality,
      meibum expressibility, MG orifice obstruction, MGD stage, and MG dropout.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 5, 2015</start_date>
  <completion_date type="Actual">May 31, 2016</completion_date>
  <primary_completion_date type="Actual">May 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change of parameters associated with dry eye syndrome</measure>
    <time_frame>baseline and 1 month after POD(postoperative day)</time_frame>
    <description>Analysis the change of parameters associated with dry eye syndrome before and after cataract surgery measured by lipiview 2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the change of parameters associated with meibomiangland dysfunction</measure>
    <time_frame>baseline and 1 month after POD(postoperative day)</time_frame>
    <description>Analysis the change of parameters associated with meibomiangland dysfunction before and after cataract surgery measured by lipiview 2.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Cataract Patients</condition>
  <arm_group>
    <arm_group_label>cataract patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cataract patients undergoing phacoemulsification</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lipiview 2</intervention_name>
    <description>Tear film lipid layer thickness and meibomian gland dropout were measured by LipiView interferometer (TearScience Inc, Morrisville, NC)</description>
    <arm_group_label>cataract patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cataract surgery planning with phacoemulsification and intraocular lens
             implantation with or without mild dry eye syndrome

        Exclusion Criteria:

          -  the previous use of eye drops, except artificial tears within 3 months before cataract
             surgery

          -  a history of previous ocular surgery or trauma

          -  the presence of ocular comorbidities such as glaucoma, uveitis, cystoid macular edema,
             and any surgical complications including rupture of the posterior capsule during
             cataract surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Ophthalmology, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>September 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2017</study_first_posted>
  <last_update_submitted>September 6, 2017</last_update_submitted>
  <last_update_submitted_qc>September 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

